which are glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog Understanding GLP Drugs: What They
Description
Its also important to discuss both the benefits of using a medication like Wegovy and its potential risks
Lancet 394 (10193), 121130
For example, the P5 exenatide analogue is biased to reduce the recruitment of -arrestin, resulting in better long-term hypoglycemic effects than those shown by exenatide, under the precondition that P5 has less cAMP activity
Journal reference: Using large language models to assess public perceptions around glucagon-like peptide-1 receptor agonists on social media
Available from: Novo Nordisk: Company announcements
